Cannabinoid Hyperemesis and Compulsive Bathing: A Case Series and Paradoxical Pathophysiological Explanation

References

1. ↵
   Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004; 53: 1566–70.

   OpenUrlAbstract/FREE Full Text
2. ↵
   Roche E, Foster PN. Cannabinoid hyperemesis: not just a problem in Adelaide Hills. Gut 2005; 54: 731.

   OpenUrlFREE Full Text
3. Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: marijuana puts patients in hot water. Australas Psychiatry 2007; 15: 156–8.

   OpenUrlAbstract/FREE Full Text
4. Budhraja V, Narang T, Slaiman A. Cannabinoid hyperemesis syndrome: cyclic vomiting, chronic canabinoid use and compulsive bathing. Pract Gastroenterol 2008; 32: 79–80.

   OpenUrl
5. Singh E, Coyle W. Cannabinoid hyperemesis. Am J Gastroenterol 2008; 103: 1048–9.

   OpenUrlPubMed
6. Chepyala P, Olden KW. Cyclic vomiting and compulsive vomiting with cannabis abuse. Clin Gastroenterol Hapatol 2008; 6: 710–2.

   OpenUrl
7. Watts M. Cannabinoid hyperemesis presenting to a New Zealand hospital. N Z Med J 2009; 122: 116–8.

   OpenUrlPubMed
8. ↵
   Chang YH, Windish DM. Cannabinoid hypersemesis relieved by compulsive bathing. Mayo Clin Proc 2009; 84: 76–8.

   OpenUrlCrossRefPubMedWeb of Science
9. Sontineni SP, Chaudsrhary S, Sontineni V, Lanspa SJ. Cannabinoid hyperemesis syndrome: clinical diagnosis of an under recognized manifestation if chronic cannabis abuse. World J Gastroenterol 2009; 15: 1264–6.

   OpenUrlCrossRefPubMedWeb of Science
10. Donnino MW, Cocchi MN, Miller J, Fisher J. Cannabinoid hyperemesis: a case series. J Emer Med 2009 [Epub ahead of print]
11. ↵
    Soriano-Co M, Batke M, Cappell MS. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States. Dig Dis Sci 2010 [Epub ahead of print]
12. ↵
    Darmani NA, Crim JL. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva). Pharmacol Biochem Behav 2005; 80: 35–44.

    OpenUrlPubMed
13. ↵
    Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 2008; 57: 1140–55.

    OpenUrlAbstract/FREE Full Text
14. ↵
    McCallum RW, Soykan I, Sridhar KR, et al. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther 1999; 13: 77–80.

    OpenUrlPubMedWeb of Science
15. ↵
    Ros J, Claria J, To-Figueras J, et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 2002; 122: 86–93.

    OpenUrl
16. ↵
    Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279–90.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    Thijssen DH, Steendijk S, Hopman MT. Blood redistribution during exercise in subjects with spinal cord injury and controls. Med Sci Sports Exerc 2009; 41: 1249–54.

    OpenUrlCrossRefPubMedWeb of Science